The direct answer: all three of these are real, FDA-cleared TENS (transcutaneous electrical nerve stimulation) devices, but their claims history isn’t equally clean. NeuroMetrix, the maker of Quell, paid a $4 million FTC settlement in 2020 for claiming Quell could relieve pain “throughout the body” and treat specific conditions like fibromyalgia and sciatica without adequate scientific evidence — a useful reminder to read every pain-device claim skeptically, including ours. Omron Avail and iReliev both stick to narrower, more defensible marketing around localized muscle and nerve stimulation.
At a Glance
- Best known brand, with a real caveat: Quell 2.0 ($300-$350) — FDA-cleared as a Class II device, but its maker was sanctioned for overstating what it does.
- Best from a mainstream medical brand: Omron Avail ($199.99) — wireless, dual-channel, from a company with a long consumer health-device track record.
- Best value with EMS included: iReliev ($199.95, often discounted) — combines TENS with EMS muscle stimulation in one wearable system.
Quell 2.0: FDA-Cleared, But Read the Claims Carefully
Quell 2.0 costs $300 for the standard kit with two electrode strips, or $350 for a version with Sport strips and a travel case. It’s worn on the upper calf and is FDA-cleared through the 510(k) pathway as a Class II medical device for chronic pain relief — that clearance is real. What isn’t accurate is the broader marketing NeuroMetrix used at one point: the FTC’s 2020 settlement specifically found the company lacked adequate scientific evidence for claims that Quell released “natural pain blockers” throughout the entire body and treated conditions like osteoarthritis, nerve damage, sciatica, shingles, and fibromyalgia specifically.
Under that settlement, NeuroMetrix is barred from repeating those specific broad claims without real supporting evidence. The device itself hasn’t changed — it’s still a legitimately cleared TENS device — but it’s a genuinely useful case study in why “FDA cleared” doesn’t automatically validate every marketing claim layered on top of a real clearance.
Omron Avail: Wireless TENS From a Mainstream Medical Brand
Omron Avail (model PM601) runs $199.99 and is a wireless, Bluetooth-connected, dual-channel TENS unit — meaning it can run two separate electrode pads independently rather than one, useful for treating two areas at once. It’s FDA-cleared, and Omron markets it more conservatively than Quell’s earlier claims: for localized pain associated with sore and aching muscles, joints, and arthritis, rather than broad full-body or condition-specific promises.
Omron’s decades-long presence in consumer medical devices (blood pressure monitors, nebulizers) gives it a longer general track record than a single-product company like NeuroMetrix, though that alone isn’t a substitute for checking any specific product’s own clearance and claims.
iReliev: TENS Plus EMS in One Wearable System
iReliev’s therapeutic wearable system runs $199.95, regularly $229.95, and is FDA-cleared per its own product listings and third-party retailer pages. Unlike the other two, it combines TENS (nerve stimulation for pain) with EMS (electrical muscle stimulation, typically used for muscle recovery and conditioning) in one wireless, rechargeable, pod-based system, with 2-pod or 4-pod configurations depending on how many areas you want to treat at once.
Because it bundles two different stimulation types rather than TENS alone, iReliev is a reasonable pick for anyone who wants both pain relief and muscle-recovery support without buying two separate devices — though it means comparing it apples-to-apples against pure TENS devices like Quell or Omron Avail isn’t perfectly clean.
Spec and Claims Comparison
| Quell 2.0 | Omron Avail | iReliev | |
|---|---|---|---|
| Price | $300-$350 | $199.99 | $199.95 (often discounted) |
| FDA status | 510(k) Class II cleared | FDA-cleared | FDA-cleared |
| Worn on | Upper calf | Wireless pads, placement flexible | Wireless pods, placement flexible |
| Stimulation type | TENS only | TENS only (dual channel) | TENS + EMS |
| Known regulatory history | 2020 FTC settlement over broad pain-relief claims | None found | None found |
Prices are approximate, current as of publication, and change frequently — confirm the latest price with the retailer before buying.
So Which One Should You Actually Buy?
Buy Omron Avail if you want straightforward, wireless dual-channel TENS from a long-established medical device brand with conservatively-worded marketing. Buy iReliev if you specifically want muscle conditioning (EMS) alongside pain relief (TENS) in one system, and don’t mind the two-in-one bundle over a pure TENS device. Consider Quell 2.0 only with the FTC history in mind — the device itself is a real, cleared TENS product, but go in skeptical of any marketing language that implies whole-body or condition-specific relief beyond what a TENS device is actually capable of.
How We Compared
We did not test any of these three devices ourselves for this comparison. Pricing, FDA clearance, and claims history were verified against each brand’s own product pages, FDA.gov filings where available, and the FTC’s own public settlement record for the Quell case specifically — we consider naming a real regulatory action directly, rather than glossing over it, part of giving readers an honest picture. More on our process is on our editorial standards page. Prices are approximate, current as of publication, and change frequently — confirm the latest price with the retailer before buying.
FAQ
What did the FTC find about Quell’s marketing claims?
In a 2020 settlement, the FTC found that NeuroMetrix, Quell’s maker, lacked adequate scientific evidence for claims that the device released “natural pain blockers” throughout the body and treated specific conditions like fibromyalgia, sciatica, and osteoarthritis. The company paid $4 million and is barred from repeating those specific claims without real supporting evidence.
Is Quell still FDA-cleared despite the FTC settlement?
Yes. The FTC action targeted marketing claims, not the device’s underlying FDA clearance — Quell 2.0 remains cleared through the 510(k) pathway as a Class II device for chronic pain relief.
What’s the difference between TENS and EMS?
TENS (transcutaneous electrical nerve stimulation) targets pain signals through the nerves. EMS (electrical muscle stimulation) directly stimulates muscle contractions, typically for conditioning or recovery. iReliev is the only device in this comparison that combines both in one system.
Who shouldn’t use a wearable TENS device?
People with pacemakers or other implanted electronic devices, pregnant women, and people with certain heart conditions should talk to a doctor before using any TENS device. Always follow the specific manufacturer’s safety guidance for your device.
Looking at recovery from a different angle? See our recovery and strain wearables comparison. Browse more in our Wearable Tech category.
